Actelion ( ALIOF ) recently announced that data on pipeline candidate Opsumit from a pivotal phase III study, SERAPHIN (Study …read more
Actelion ( ALIOF ) recently announced that data on pipeline candidate Opsumit from a pivotal phase III study, SERAPHIN (Study …read more